fda warning letters compounded tirzepatide 2024 2025 weight loss injections — knock-offs are not the same – Partnership for Safe Medicines National Hispanic Medical Association |

Key insights from The Atlantic: 14 million adults on Medicaid suffer from obesity, but only 13 states currently cover GLP-1s for weight management These drugs reduce weight by 15-20% and show benefits for diabetes, cardiovascular disease, liver/kidney disease, and even substance abuse Budget fears may be overblown: with Medicaid negotiation power and falling prices, costs could be offset by 27%+ through reduced healthcare spending At projected Medicaid prices (~$235/month), covering 10% of eligible patients would increase Medicaid spending by just 0.4% For communities like zip code 78207 facing a diabetes crisis, this isnt just about weight lossits about access to life-saving medication that could add 3-4 years to life expectancy while reducing complications from multiple chronic conditions

,

RAAS blockers remain essential for managing hypertension and reducing proteinuria, crucial for preventing further kidney damage[3]

These feelings are a direct result of the medication working as intended

The mean age was 72 SD 10 years, 46% were women and the majority were in New York Heart Association functional class II (69%)